SFI Health Solutions

What SFI Health Solutions does

SFI Health Solutions is a privately held contract development and manufacturing organization (CDMO) specializing in natural pharmaceutical and nutraceutical products, operating as the commercial brand of Australian parent Soho Flordis International Pty Limited. The company runs a four-site global manufacturing network anchored by a 20,000 m2 GMP-certified facility in Bioggio, Switzerland (opened 1979, producing 450+ product references), supplemented by production sites in Reno, USA; Wigan, UK; and a sister-company facility in Jakarta, Indonesia; plus a regional office in St Leonards, Australia. It services enterprise pharmaceutical, nutraceutical, and consumer-goods customers across more than 100 countries.

The commercial offering is built on a proprietary three-pillar methodology — Design, Develop, Deliver — covering formulation and regulatory affairs, agile iterative development with in-house analytical and microbiological laboratories, and flexible at-scale manufacturing across tablets, capsules, powders, and liquids. The technology stack is anchored by domain specialization in natural ingredients (EMEA-focused on botanicals, vitamins, and minerals; Americas-focused on live cultures, strains, spores, yeast, bacteria, and fungi) and by a dense regulatory credential set including GMP, MHRA, FDA, HACCP, NSF, ANVISA, SFDA, and TGA, plus the ability to apply a 'Swiss Made' quality label to products manufactured at Bioggio.

The business operates on two revenue streams: professional services revenue from project-based CDMO contracts for formulation, development, and manufacturing of OTC, herbal, and food supplement products; and licensing/royalty revenue from nine ready-to-market private label SKUs spanning cardiovascular, cognitive, immune, digestive, sleep, and maternal health categories. Go-to-market is direct enterprise field sales supported by Vitafoods conference participation, LinkedIn, SEO, and content marketing via published case studies demonstrating quantifiable outcomes (e.g., 30% flagship-product sales increase, 50% expected client sales growth, capsule-to-tablet conversion in six weeks). Pricing is quote-based and not publicly disclosed.

Name

SFI Health Solutions

Legal name

Soho Flordis International Pty Limited

Website

https://sfihealthsolutions.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

SFI Health Solutions is a privately held, Switzerland-headquartered CDMO that designs, develops, and manufactures natural pharmaceutical and nutraceutical products for enterprise pharmaceutical, nutraceutical, and consumer-goods clients across 100+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Development and Manufacturing (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417), Management, Scientific, and Technical Consulting Services (5416)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

Keywords

• Contract pharmaceutical manufacturing
• Nutraceutical development services
• Private label supplements
• Pharmaceutical contract research
• Natural product formulation

Headquarters

HQ city

Bioggio

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

1. Contract Development and Manufacturing Services: Full-service CDMO providing formulation, development, and manufacturing services for pharmaceutical and nutraceutical products. Revenue generated through project-based contracts for design services, development services, and manufacturing/delivery services across tablets, capsules, powders, and liquids.
2. Private Label Products: Ready-to-market private label nutraceutical product formulations available for branding by clients, including cardiovascular, cognitive, immune, digestive, and sleep health products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

SFI Health Solutions is a full-service Contract Development and Manufacturing Organisation (CDMO) that provides formulation design, agile product development, and scale manufacturing of pharmaceutical and nutraceutical products (OTC products, herbal products, food supplements, capsules, tablets, powders and liquids) across facilities in Switzerland, the UK, the USA and an Indonesian sister plant. It complements these services with a portfolio of ready-to-market private label supplement formulations (cardiovascular, cognitive, immune, digestive, sleep, energy and pregnancy) that clients can brand and distribute. The company is organised around three interconnected service pillars — Design, Develop and Deliver — with regulatory affairs, analytical laboratories and global distribution support.

Product overview

SFI Health Solutions is a full-service Contract Development and Manufacturing Organisation (CDMO) specializing in pharmaceutical and nutraceutical products. The company operates through three interconnected service pillars: Contract Design (formulation, regulatory affairs, pre-clinical/clinical support), Contract Develop (agile development, formulation, QA/QC, packaging), and Contract Deliver (manufacturing at scale). The company offers a portfolio of nine private label supplement products including CardioProtectDuo (cardiovascular), CardioCare (Omega 3), PhytoRest (sleep/melatonin), Day&Night (wellbeing), MemorEase (cognitive), NutriMom (pregnancy), OptiGut (digestive), PerforManGO (energy), and PhytoDefense (immune support). Production facilities are located in the USA, UK, Switzerland, and Indonesia.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Design Services Formulation and product design services for nutraceutical and pharmaceutical clients, covering formulation ideas, label claims evaluations, product delivery formats, improvements and reformulations, medical review, pre-clinical and clinical trial support, and regulatory affairs.
• Contract Develop Services Agile development services for OTC, herbal and food supplement products, including formulation, strategic sourcing, small-batch R&D trials, regulatory review, chemical and microbiological analysis, QA/QC, shelf-stability evaluation and packaging, using a rapid iterative development process.
• Contract Deliver Services Full-scale CDMO manufacturing services delivered through GMP-certified facilities producing film-coated tablets, capsules, powders and liquids, with flexibility to pivot with market changes and supply-chain disruptions.
• CardioProtectDuo (Private Label) Private label supplement supporting healthy cardiovascular function, improving blood flow, blood pressure and blood vessel integrity; intended for nutraceutical brands that want to launch a ready-to-brand cardiovascular product.
• CardioCare (Private Label) Private label Omega-3 fatty acid supplement for cardiovascular health; ready-to-brand formulation for nutraceutical companies.
• PhytoRest (Private Label) Plant-based melatonin supplement tablet supporting mental relaxation and sleep quality, combining zinc for normal cognitive function and melatonin to reduce time taken to fall asleep; ready-to-brand for sleep-aiding supplement brands.
• Day&Night (Private Label) Natural wellbeing supplements and natural sleep supplements designed to support mental and physical wellness across the day and night cycle; ready-to-brand formulation for wellbeing brands.
• MemorEase (Private Label) Herbal supplement supporting calm mental focus, memory and relief from anxiety; ready-to-brand formulation for cognitive-health supplement brands.
• NutriMom (Private Label) Omega-6 and Omega-3 fatty acid supplement for pregnancy, providing fish oil 600mg (DHA 300mg, EPA 42mg) and evening primrose oil 150mg (GLA 15mg) to support women before, during and after pregnancy; ready-to-brand for maternal-nutrition brands (sale outside Europe per product page).
• OptiGut (Private Label) Natural digestive supplement supporting gastrointestinal health and digestive wellness; ready-to-brand formulation for gut-health supplement brands.
• PerforManGO (Private Label) Natural supplement for energy and focus to combat tiredness and support mental performance; ready-to-brand formulation for energy-and-focus supplement brands.
• PhytoDefense (Private Label) Immune support supplement that strengthens and balances the immune system and helps tackle infections while reducing inflammatory discomfort; ready-to-brand formulation for immune-support supplement brands.

Quantifiable outcome

• 50% expected growth of product sales over next 2 years for sustainable packaging client
• +5 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Eurofins CDMO: Global CDMO services combined with analytical testing infrastructure. Comparable to SFI's in-house QC/analytical laboratories paired with manufacturing, though operating on a much larger testing and manufacturing footprint.
• Lonza Group: Swiss-headquartered global CDMO with manufacturing for pharma, consumer health, and nutrition. Comparable to SFI in Swiss heritage and international CDMO positioning, but operates across a much wider technology portfolio including biologics.
• Recipharm: European CDMO offering development and manufacturing services across solid, semi-solid, and other dosage forms. Comparable to SFI in serving pharma and nutraceutical customers, but at significantly larger scale across multiple categories.
• Catalent: Global CDMO providing development and manufacturing for pharma and consumer health across a wide range of dosage forms. Comparable to SFI in serving nutraceutical and OTC customers, but at materially larger scale and broader technology scope.
• Baxter BioPharma Solutions: Global CDMO providing sterile injectable and oral dose manufacturing. Comparable to SFI in offering GMP-compliant contract manufacturing for pharma and consumer health, but with a more biologics-centric portfolio.
• PCI Pharma Services: Global CDMO providing commercial-scale manufacturing, packaging, and serialization for pharma and consumer health. Comparable to SFI in serving multinational pharma and supplement brands with integrated development-through-delivery services.

Direct peers

• NextPharma: European CDMO offering contract development and manufacturing for pharma, biotech, and consumer health products. Comparable to SFI in multi-site European production, solid-dose capabilities, and nutraceutical/OEM services.
• Aenova Group: German-headquartered CDMO with strong dose-form capabilities (tablets, capsules, softgels) for pharma and nutraceutical customers. Closely comparable to SFI in target customer base, product format, and European manufacturing footprint.
• Hermes Arzneimittel: German CDMO with a focus on herbal and plant-based pharmaceutical products and OTC supplements. Closely comparable to SFI's EMEA specialization in botanicals, herbal extracts, and natural OTC formulations.
• Temmler Pharma: European CDMO providing formulation, development, and manufacturing for pharmaceutical and consumer health products. Comparable to SFI in solid dose contract manufacturing for European pharma and nutraceutical clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/SFIHealth
• LinkedInlinkedin.com/company/sfi-health-solutions

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SFI Health Solutions